Doctor profile · Federal record

Dr. Stephen Zrada, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Cherry Hill, NJ

  • NPI 1407852676
  • Accepts Medicare
  • MIPS 79.9 / 100 · 2023
  • 31 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1865 Route 70 East, Ste 220
Cherry Hill, NJ 080032013
(856) 429-1519
fax (856) 427-0250
Additional location
1930 Route 70 E, Ste V107
Cherry Hill, NJ 080034212
(856) 424-3311
fax (856) 424-5634
Mailing address
51 N 39Th St
Philadelphia, PA 191044206

Credentials & registration

NPPES · NUCC
NPI registered
June 2005 — 21 yrs on file
Profile last updated
January 16, 2026
Year of graduation
1995 — 31 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (2)
New Jersey #25MA07352100 · Pennsylvania #MD069087L
Medicaid
NJ #8725501

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1407852676. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
58,394
Distinct HCPCS
10
Medicare allowed
$1,603,415
HCPCS Description Services Patients Avg allowed
J1756 Injection, iron sucrose, 1 mg 12,801 19 $0
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 11,160 11 $48
J9271 Injection, pembrolizumab, 1 mg 10,000 18 $54
J1453 Injection, fosaprepitant, 1 mg 8,250 24 $0
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 3,410 14 $7
J0897 Injection, denosumab, 1 mg 2,940 14 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,128 32 $0
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 910 11 $7
J2405 Injection, ondansetron hydrochloride, per 1 mg 862 27 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 802 391 $136

In context: peer comparison

Among 5 peers in Cherry Hill Hematology & Oncology Physician, average services per provider: 760. This provider delivers 77× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$6,061
Transactions
29
Manufacturers
11
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 11 $4,636.78
BeiGene USA, INC. 1 $675.00
Astellas Pharma US INC 2 $194.98
Novocure INC. 2 $167.38
Regeneron Healthcare Solutions, INC. 3 $134.87
Aveo Pharmaceuticals, INC. 1 $89.99
E.R. Squibb & Sons, L.L.C. 3 $47.49
Menarini Silicon Biosystems, INC. 2 $43.32
GlaxoSmithKline, LLC. 2 $34.19
Myriad Genetic Laboratories, INC. 1 $22.75
Merck Sharp & Dohme LLC 1 $14.72

By nature of payment

Consulting Fee
$5,120
Food and Beverage
$781
Education
$160

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
554
Patients
230
Total drug cost
$943,658
Drug Type Claims Patients Total cost
Anastrozole Generic 194 62 $6,352
Ondansetron Hcl Generic 76 57 $525
Prochlorperazine Maleate Generic 61 53 $630
Letrozole Generic 50 21 $1,850
Hydroxyurea Generic 34 13 $1,033
Exemestane Generic 30 0 $5,558
Imbruvica (Ibrutinib) Brand 21 0 $337,692
Lidocaine-Prilocaine (Lidocaine/Prilocaine) Brand 15 13 $161
Ibrance (Palbociclib) Brand 14 0 $219,929
Calquence (Acalabrutinib Maleate) Brand 13 0 $190,087

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Stephen Zrada's medical specialty?
Dr. Stephen Zrada practices Hematology & Oncology Physician in Cherry Hill, NJ.
Where does Dr. Stephen Zrada practice?
Dr. Stephen Zrada practices at 1865 Route 70 East, Cherry Hill, NJ 080032013. Office phone: 8564291519.
What is Dr. Stephen Zrada's NPI?
Dr. Stephen Zrada's National Provider Identifier (NPI) is 1407852676, issued by NPPES.
Does Dr. Stephen Zrada accept Medicare assignment?
Yes. Dr. Stephen Zrada accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stephen Zrada commonly perform?
Top Medicare-reported procedures in 2023: Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.